Medical Care Technologies Inc. Launches Updated Website, Outlines AI Roadmap

Medical Care Technologies Inc. (OTC PINK:MDCE) announced on April 30, 2026, the launch of a newly redesigned corporate website at medicalcaretechnologies.com. The update provides investors with expanded visibility into the company's strategic roadmap, operational priorities, and long-term growth initiatives across artificial intelligence and healthcare verticals.

The press release, distributed via ACCESS Newswire, outlines a multi-phase roadmap spanning short-term execution, near-term development milestones, and long-term strategic objectives. This is the kind of structured disclosure that matters for OTC PINK-listed companies trying to establish credibility with institutional investors.

Short-term goals focus on execution and capital efficiency. The company plans to liquidate up to $250,000 in subsidiary-owned assets to support AI research, development, and production—approximately $200,000 has been obtained thus far. They're also launching an upgraded version of their AI mobile application, Snapshot Recipes, alongside a restructured marketing strategy. Revenue generation continues from subsidiaries Infinite Auctions and Real Game Used.

Near-term 2026 goals center on advancing AI capabilities and entering the medical application space. The company is developing one or more medical-grade beta applications with structured beta testing initiatives, including collaboration with academic groups. They're also exploring venture capital opportunities in artificial intelligence for potential partnerships and looking to purchase existing AI tech and innovative mobile applications to add to their library.

Long-term objectives for 2027 and beyond include exploring clinical and institutional partnerships for healthcare-focused applications, evaluating regulatory pathways for medical-grade AI technologies, and pursuing an uplisting to the OTCQB, subject to meeting qualification requirements. The company is also advancing its provisional patent related to patent-pending AI image analysis technology.

CEO Marshall Perkins stated that transparency, execution, and communication are critical as the company continues to build. He emphasized that the updated platform gives investors a clear view of the roadmap while committing to improving shareholder communication through more direct updates and real-time question addressing on X. (The social media angle is interesting—most OTC companies still treat investor relations as a quarterly formality.)

The capital strategy includes a Regulation A intended to serve as a strategic funding tool if there's a rebound in the price per share. The company is also pursuing non-dilutive initiatives, including the sale of subsidiary-owned assets, to support development while maintaining a balanced capital approach.

Snapshot Recipes represents the company's strategic pivot into high-adoption, consumer-focused artificial intelligence applications. Available at snapshotrecipes.app, the platform uses advanced AI to instantly generate customized recipes using either a photo of available ingredients or a saved image of a meal users want to recreate. Within seconds, users receive step-by-step cooking instructions, complete nutrition facts, and a visually stunning AI-generated dish image.

The application has already demonstrated strong early performance during testing, reaching #11 in the iOS App Store Food & Drink category. This validates both consumer demand and market scalability before the full-scale launch and marketing rollout. The physical experience matters here—users snap a photo, wait a few seconds while the AI processes the image, and get immediate results. It's the kind of frictionless interaction that drives adoption.

The company's proprietary AI imaging platform, now patent-pending (U.S. Provisional Patent Application No. 63/854,935), represents a breakthrough in mobile diagnostics. Built on advanced deep learning, temporal image analysis, and affective computing, this platform transforms an ordinary smartphone into a powerful diagnostic tool, enabling real-time health screenings and disease risk detection without specialized equipment.

Medical Care Technologies is engineering a portfolio of AI-driven healthcare, dietary, and wellness mobile applications that address diagnostic gaps across multi-billion-dollar markets. Each vertical is powered by a proprietary patent-pending deep learning engine, designed to scale globally and deliver measurable impact for patients, providers, and payers. The company plans to launch its first wave of AI-integrated mobile applications in 2026, bringing these technologies to consumers in over 127 countries in 30 different languages.

The company also announced it reached #2 on the InvestorsHub breakout board, reflecting a surge in investor attention following recent strategic updates. This increased visibility highlights growing market awareness as investors evaluate MDCE's expanding position across artificial intelligence, healthcare applications, and commercial technology platforms.

Whether the OTCQB uplisting materializes depends on meeting qualification requirements that many micro-cap companies struggle to satisfy. The asset liquidation strategy provides near-term capital, but the medical-grade applications face longer development cycles and regulatory hurdles. Investors should weigh the consumer app revenue potential against the clinical validation timeline. The website update is a transparency move, but execution remains the real test.

Artūras Malašauskas is an AI Systems Integrator with 20+ years of production-grade web engineering experience. He has designed, shipped, and scaled enterprise Python/PHP systems for logistics, SaaS, and public-sector clients. For the past year, he has focused exclusively on AI integrations: deploying open-source LLMs, building generative media pipelines (image, audio, video), and engineering multi-agent workflows for real production environments. His standard: reproducibility, security, cost-efficient inference—no vaporware. He documents and evaluates emerging AI tooling, separating verified capabilities from marketing noise. Technical editor at: muza-ai.eu, ai-verslas.lt, ai-naujinos.lt Connect on LinkedIn